Liraglutide
Liraglutide from the Nexus GLP-1 & Metabolic catalog, supplied for controlled in-vitro research workflows.
Ships from the US with tracking.
Catalog active: Catalog pricing is active. Live warehouse counts are not published.
- Lot-specific COA
- HPLC + MS fields
- Batch archived
For in-vitro research use only. Not for human consumption.
Liraglutide is a GLP-1 receptor agonist sharing 97% sequence homology with native GLP-1. Its C-16 palmitic acid modification enables non-covalent albumin binding, extending research half-life compared to native GLP-1 but shorter than Semaglutide. It activates GLP-1 receptors involved in glucose homeostasis and metabolic signaling.
No sequence is listed in the current catalog record for this product.
- CAS
- 204656-20-2
- MW
- 3751.20 g/mol
- Sequence
- Not listed
- Half-life
- Discussed in research notes
- Formula
- C172H265N43O51
- Purity
- 99.84%
- Form
- Lyophilized powder
- Class
- GLP-1 Receptor Agonist
The dossier.
Compound Overview
Liraglutide is a GLP-1 receptor agonist with 97% sequence homology to native GLP-1. The compound includes a C-16 palmitic acid modification that supports non-covalent albumin binding, giving it an extended research half-life relative to native GLP-1 while remaining shorter than Semaglutide. In controlled laboratory systems, it activates GLP-1 receptors involved in glucose homeostasis and metabolic signaling.
Research Background & Published Literature
Liraglutide is widely referenced in GLP-1 receptor pharmacology literature, including published LEAD and SCALE research programs. Researchers use it as a benchmark compound for studying GLP-1 receptor activity and metabolic signaling pathways in controlled experimental contexts.
Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:
Storage, Handling & Stability Guidelines
Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.
- Keep ambient-temperature handling time as short as practical to support compound integrity.
- Reseal vials promptly after each withdrawal to limit moisture exposure.
- Use appropriate personal protective equipment and follow institutional chemical safety protocols at all times.
- For traceability, label all aliquots with compound name, concentration, reconstitution date, and operator initials.
Quality Assurance & Lab Verification
A finalized public Certificate of Analysis is available for this catalog item. Review the public COA for the applicable lot. Lot-specific identifiers, assay values, and methods are maintained in that record and are not repeated in this product dossier.
Shipping
Orders ship within the United States via USPS; international orders are not accepted. Laboratories should follow their validated SOP together with any handling fields published for the represented product or lot; no universal prepared-solution condition is inferred here.
Compound details.
- CAS Number
- 204656-20-2
- Molecular Weight
- 3751.20 g/mol
- Molecular Formula
- C₁₇₂H₂₆₅N₄₃O₅₁
- Class
- GLP-1 Receptor Agonist
Research context.
The active ingredient in Victoza and Saxenda, Liraglutide has been studied in the LEAD and SCALE clinical trial programs. It serves as a benchmark compound for GLP-1 receptor pharmacology and metabolic signaling research.
Verification standard.
Certificate information is lot-specific. A finalized public record shows only the methods, fields, and results present for that named lot. A pending certificate state exposes no assay values and must not be interpreted as analytical verification. Review Nexus lab verification.
Analytical record.
- Reported HPLC purity
- 99.84%
- Retention time
- 16.00 min
- Observed mass
- 3751.26 Da
- Batch
- APX-2026-0413-L
The normalized Certificate of Analysis publishes only the lot-specific fields represented in the public record. It is not an originating laboratory report or raw instrument file.
View certificate of analysis - batch APX-2026-0413-L- Sequence
- Not listed
- Model preview
- Unavailable
Molecular model preview is unavailable for this catalog record.
The chemistry.
31-amino acid GLP-1 analog with C-16 palmitic acid modification
Technical specifications.
- Product Name: Liraglutide
- Classification: GLP-1 Receptor Agonist
- Structural Description: 31-amino acid GLP-1 analog with C-16 palmitic acid modification
- CAS Number: 204656-20-2
- Molecular Weight: 3751.20 g/mol
- Purity: ≥99% (verified by HPLC and Mass Spectrometry)
- Physical Form: Lyophilized (freeze-dried) powder
- Intended Use: In-vitro research use only — not for human consumption
Related research compounds
Comparable catalog records with published variants and certificate status.
- GLP-1 & MetabolicVerified batchSemaglutidePriceFrom $14.99Formats6 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 910463-68-2View product - GLP-1 & MetabolicVerified batchTirzepatidePriceFrom $28.99Formats10 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 2023788-19-2View product - GLP-1 & MetabolicVerified batchRetatrutidePriceFrom $45.99Formats8 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 2381089-83-2View product - GLP-1 & MetabolicVerified batchMazdutidePriceFrom $94.99Formats2 sizes
Compare size options, price, and certificate status before opening the product record.
CAS 2259884-03-0View product - GLP-1 & MetabolicVerified batchSurvodutidePrice$342.99Formats1 size
Compare size options, price, and certificate status before opening the product record.
CAS 2805997-46-8View product
Liraglutide research FAQ.
What is Liraglutide used for in research?
Liraglutide is supplied for controlled in-vitro research workflows in the GLP-1 & Metabolic category. It is not labeled for human or veterinary use.
Does Liraglutide have a finalized analytical record?
Liraglutide has a finalized Nexus Lab Verified record that reports 99.84% HPLC area-percent purity for the represented batch. Other fields are shown only where present.
Which Liraglutide variants are published?
Published Nexus variants include 5mg, 10mg, 30mg.
Does Liraglutide include a COA?
Yes. The current Nexus record links Liraglutide to finalized batch APX-2026-0413-L.